LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 22

Search options

  1. Article: Vascular dysregulation in glaucoma: retinal vasoconstriction and normal neurovascular coupling in altitudinal visual field defects.

    Zhou, Wanshu / Sabel, Bernhard A

    The EPMA journal

    2023  Volume 14, Issue 1, Page(s) 87–99

    Abstract: Purpose: Vision loss in glaucoma is not only associated with elevated intraocular pressure and neurodegeneration, but vascular dysregulation (VD) is a major factor. To optimize therapy, an improved understanding of concepts of predictive, preventive, ... ...

    Abstract Purpose: Vision loss in glaucoma is not only associated with elevated intraocular pressure and neurodegeneration, but vascular dysregulation (VD) is a major factor. To optimize therapy, an improved understanding of concepts of predictive, preventive, and personalized medicine (3PM) is needed which is based on a more detailed understanding of VD pathology. Specifically, to learn if the root cause of glaucomatous vision loss is of neuronal (degeneration) or vascular origin, we now studied neurovascular coupling (NVC) and vessel morphology and their relationship to vision loss in glaucoma.
    Methods: In patients with primary open angle glaucoma (POAG) (
    Results: Retinal arterial and venous vessels had significantly smaller diameters in patients with POAG in comparison to controls. However, both arterial and venous dilation reached normal values during neuronal activation despite their smaller diameters. This was largely independent of visual field depth and varied among patients.
    Conclusions: Because dilation/constriction is normal, VD in POAG can be explained by chronic vasoconstriction which limits energy supply to retinal (and brain) neurons with subsequent hypo-metabolism ("silent" neurons) or neuronal cell death. We propose that the root cause of POAG is primarily of vascular and not neuronal origin. This understanding can help to better personalize POAG therapy of not only targeting eye pressure but also vasoconstriction to prevent low vision, slowing its progression and supporting recovery and restoration.
    Trial registration: ClinicalTrials.gov, # NCT04037384 on July 3, 2019.
    Language English
    Publishing date 2023-02-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2545928-4
    ISSN 1878-5085 ; 1878-5077
    ISSN (online) 1878-5085
    ISSN 1878-5077
    DOI 10.1007/s13167-023-00316-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Vascular dysregulation in glaucoma

    Zhou, Wanshu / Sabel, Bernhard A.

    EPMA Journal

    Retinal vasoconstriction and normal neurovascular coupling in altitudinal visual field defects

    2023  Volume 14, Page(s) 87–99

    Abstract: Purpose: Vision loss in glaucoma is not only associated with elevated intraocular pressure and neurodegeneration, but vascular dysregulation (VD) is a major factor. To optimize therapy, an improved understanding of concepts of predictive, preventive, and ...

    Title translation Vaskuläre Dysregulation bei Glaukom: Retinale Vasokonstriktion und normale neurovaskuläre Kopplung bei höhenabhängigen Gesichtsfelddefekten
    Abstract Purpose: Vision loss in glaucoma is not only associated with elevated intraocular pressure and neurodegeneration, but vascular dysregulation (VD) is a major factor. To optimize therapy, an improved understanding of concepts of predictive, preventive, and personalized medicine (3PM) is needed which is based on a more detailed understanding of VD pathology. Specifically, to learn if the root cause of glaucomatous vision loss is of neuronal (degeneration) or vascular origin, we now studied neurovascular coupling (NVC) and vessel morphology and their relationship to vision loss in glaucoma. Methods: In patients with primary open angle glaucoma (POAG) (n = 30) and healthy controls (n = 22), NVC was studied using dynamic vessel analyzer to quantify retinal vessel diameter before, during, and after flicker light stimulation to evaluate the dilation response following neuronal activation. Vessel features and dilation were then related to branch level and visual field impairment. Results: Retinal arterial and venous vessels had significantly smaller diameters in patients with POAG in comparison to controls. However, both arterial and venous dilation reached normal values during neuronal activation despite their smaller diameters. This was largely independent of visual field depth and varied among patients. Conclusions: Because dilation/constriction is normal, VD in POAG can be explained by chronic vasoconstriction which limits energy supply to retinal (and brain) neurons with subsequent hypo-metabolism ("silent" neurons) or neuronal cell death. We propose that the root cause of POAG is primarily of vascular and not neuronal origin. This understanding can help to better personalize POAG therapy of not only targeting eye pressure but also vasoconstriction to prevent low vision, slowing its progression and supporting recovery and restoration.
    Keywords Blood Flow ; Blood Vessels ; Blutfluss ; Blutgefäße ; Glaucoma ; Grüner Star ; Neurodegeneration ; Precision Medicine ; Prediction ; Prevention ; Prävention ; Präzisionsmedizin ; Sehfeld ; Sehstörungen ; Vasoconstriction ; Vasokonstriktion ; Vision Disorders ; Visual Field ; Vorhersage
    Language English
    Document type Article
    ZDB-ID 2545928-4
    ISSN 1878-5085 ; 1878-5077
    ISSN (online) 1878-5085
    ISSN 1878-5077
    DOI 10.1007/s13167-023-00316-6
    Database PSYNDEX

    More links

    Kategorien

  3. Article ; Online: Intermittent administration sodium valproate has a protective effect on bone health in ovariectomized rats.

    Tao, Zhou-Shan / Zhou, Wan-Shu / Xu, Hong-Guang / Yang, Min

    European journal of pharmacology

    2021  Volume 906, Page(s) 174268

    Abstract: The present work was aimed to evaluate the effect of different administration modes of sodium valproate (VPA) on bone strength, bone mass and bone mineral density in ovariectomized (OVX) rats and further investigation of the possible mechanism. 60 female ...

    Abstract The present work was aimed to evaluate the effect of different administration modes of sodium valproate (VPA) on bone strength, bone mass and bone mineral density in ovariectomized (OVX) rats and further investigation of the possible mechanism. 60 female SD rats were randomly divided into 4 groups: Sham group (Sham, n = 15), OVX group (OVX, n = 15), OVX rats received intermittent VPA treatment group (IVPA, n = 15) and OVX rats received daily VPA treatment group (EVPA, n = 15). After 12 weeks of treatment, the rats were sacrificed, and serum and femur samples were harvested. DEXA, Micro-CT, history, biomechanical testing, biochemical index and western blot analysis were used to observe the therapeutic effect and explore the possible mechanism. Micro-CT and DEXA analysis of bones revealed better BMD and higher BV/TV, Tb. Th, Tb. N, Conn. D and lower Tb. Sp at femoral metaphysis evaluated in IVPA when compared with OVX and EVPA group (P < 0.05). Histological, fluorescent analysis and biological strength revealed more trabecular bone and higher relative mineral apposition rate, maximal load, elastic modulus and energy at break with evaluated in IVPA when compared with OVX and EVPA group (P < 0.05). The levels of P1NP, estrogen, CTX, TRAP-5b and RANKL of the IVPA group showed a significant increase when compared with the OVX and EVPA group (P < 0.05). We confirm adverse effects on protein expressions including Notch1, Jagged1, HEY1, Wnt 1, β-catenin and RUNX2 following daily VPA treatment in OVX female rats. Our current study demonstrated that intermittent administration of sodium valproate has a protective effect on bone health in OVX rats and these effects may be achieved by activating Notch/Wnt/β-catenin/RUNX2 signal axis.
    MeSH term(s) Animals ; Bone Density/drug effects ; Bone Density/physiology ; Cancellous Bone/diagnostic imaging ; Cancellous Bone/drug effects ; Cancellous Bone/metabolism ; Core Binding Factor Alpha 1 Subunit/metabolism ; Disease Models, Animal ; Drug Administration Schedule ; Estrogens/metabolism ; Female ; Humans ; Menopause/metabolism ; Osteoporosis, Postmenopausal/diagnosis ; Osteoporosis, Postmenopausal/etiology ; Osteoporosis, Postmenopausal/pathology ; Osteoporosis, Postmenopausal/prevention & control ; Ovariectomy/adverse effects ; Rats ; Rats, Sprague-Dawley ; Receptors, Notch/metabolism ; Valproic Acid/administration & dosage ; Wnt Signaling Pathway/drug effects ; Wnt Signaling Pathway/physiology ; X-Ray Microtomography
    Chemical Substances Core Binding Factor Alpha 1 Subunit ; Estrogens ; Receptors, Notch ; Runx2 protein, rat ; Valproic Acid (614OI1Z5WI)
    Language English
    Publishing date 2021-06-22
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 80121-5
    ISSN 1879-0712 ; 0014-2999
    ISSN (online) 1879-0712
    ISSN 0014-2999
    DOI 10.1016/j.ejphar.2021.174268
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Combined phacoemulsification and goniosynechialysis with or without endoscopic cyclophotocoagulation in the treatment of PACG with cataract.

    Zhou, Wan-Shu / Lin, Wen-Xiang / Geng, Yun-Yun / Wang, Tao

    International journal of ophthalmology

    2020  Volume 13, Issue 9, Page(s) 1385–1390

    Abstract: Aim: To investigate the efficacy and safety of combined phacoemulsification and goniosynechialysis with or without endoscopic cyclophotocoagulation (PGE group and PG group) for the treatment of patients with coexisting primary angle-closure glaucoma ( ... ...

    Abstract Aim: To investigate the efficacy and safety of combined phacoemulsification and goniosynechialysis with or without endoscopic cyclophotocoagulation (PGE group and PG group) for the treatment of patients with coexisting primary angle-closure glaucoma (PACG) and cataracts.
    Methods: The clinical data of patients with PACG and cataract were retrospectively reviewed. There was a total of 88 eyes in the study and were divided into two groups, 42 eyes in PGE group and 46 eyes in PG group. Surgery success cumulative survival, preoperative and postoperative intraocular pressure (IOP), number of IOP-lowering medications, best corrected visual acuity (BCVA) in the two groups were observed for more than 12mo and compared within each group and between two groups.
    Results: The mean IOP in PGE group declined from 24.9 mm Hg preoperatively to 14.1 mm Hg at the first month after operation (
    Conclusion: PGE shows promise for PACG patients with cataracts to reduce IOP, lighten the medication burden and improve visual acuity, and PG still has its value in specific patients.
    Language English
    Publishing date 2020-09-18
    Publishing country China
    Document type Journal Article
    ZDB-ID 2663246-9
    ISSN 2227-4898 ; 2222-3959
    ISSN (online) 2227-4898
    ISSN 2222-3959
    DOI 10.18240/ijo.2020.09.08
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Parathyroid hormone (1-34) can reverse the negative effect of valproic acid on the osseointegration of titanium rods in ovariectomized rats.

    Tao, Zhou-Shan / Zhou, Wan-Shu / Xu, Hong-Guang / Yang, Min

    Journal of orthopaedic translation

    2020  Volume 27, Page(s) 67–76

    Abstract: Objective: The present work was aimed to evaluate the effect of valproic acid (VPA),Parathyroid hormone (1-34) (PTH)+VPA on Ti rods osseointegration in ovariectomized rats and further investigation of the possible mechanism.: Methods: The MC3T3-E1 ... ...

    Abstract Objective: The present work was aimed to evaluate the effect of valproic acid (VPA),Parathyroid hormone (1-34) (PTH)+VPA on Ti rods osseointegration in ovariectomized rats and further investigation of the possible mechanism.
    Methods: The MC3T3-E1 cells were co-cultured with VPA,PTH ​+ ​VPA and induced to osteogenesis, and the cell viability,mineralization ability were observed by MTT and ALP staining,Alizarin Red staining and Western blotting. Twelve weeks after bilateral ovariectomy, all animals were randomly divided into four groups: group OVX and VPA,PTH ​+ ​VPA, and all the rats received Ti implants and animals belong to group VPA,PTH ​+ ​VPA received valproic acid (300 ​mg/day), valproic acid (300 ​mg/day) plus Parathyroid hormone (1-34) every 3 days (60 ​μg/kg), respectively, treatment until death at 12 weeks. Micro-CT, histology, biomechanical testing, bone metabolism index and Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis were used to observe the therapeutic effect and explore the possible mechanism.
    Results: Results shown that VPA decreased new bone formation around the surface of titanium rods and push-out force other than group OVX. Histology, Micro-CT and biochemical analysis results showed combined application of systemic VPA showed harmful effects than OVX group on bone formation in osteopenia rats, with the worse effects on CTX-1, P1NP and microarchitecture as well as biomechanical parameters by down-regulated gene expression of Runx2, OCN, Smad1, BMP-2 and OPG, while up-regulated RANKL. However, after PTH treatment, the above indicators were significantly improved.
    Conclusions: The present study suggests that systemic use of VPA may bring harm to the stability of titanium implants in osteoporosis, PTH can reverse the negative effect of VPA on the osseointegration of titanium rods in ovariectomized rats.
    Translational potential of this article: According to our research, when patients with epilepsy have osteoporotic fractures, after joint replacement or internal fixation, continue to use sodium valproate for anti-epileptic therapy, the possibility of postoperative loosening increases, again on the basis of It can be reversed with the anti-osteoporosis drug parathyroid hormone (1-34).
    Language English
    Publishing date 2020-12-28
    Publishing country Singapore
    Document type Journal Article
    ZDB-ID 2747531-1
    ISSN 2214-031X
    ISSN 2214-031X
    DOI 10.1016/j.jot.2020.10.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Simvastatin can enhance the osseointegration of titanium rods in ovariectomized rats maintenance treatment with valproic acid.

    Tao, Zhou-Shan / Zhou, Wan-Shu / Xu, Hong-Guang / Yang, Min

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2020  Volume 132, Page(s) 110745

    Abstract: The present work was aimed to evaluate the effect of valproic acid(VPA), simvastatin (SIM)+VPA on Ti(titanium) rods osseointegration in ovariectomized(OVX) rats and further investigation of the possible mechanism. The MC3T3-E1 cells were co-cultured with ...

    Abstract The present work was aimed to evaluate the effect of valproic acid(VPA), simvastatin (SIM)+VPA on Ti(titanium) rods osseointegration in ovariectomized(OVX) rats and further investigation of the possible mechanism. The MC3T3-E1 cells were co-cultured with VPA, SIM + VPA and induced to osteogenesis, and the cell viability, mineralization ability were observed by MTT and ALP staining, Alizarin Red staining and Western blotting. Twelve weeks after bilateral ovariectomy, all animals were randomly divided into three groups: group OVX and VPA, SIM + VPA, and all the rats received Ti implants and animals belong to group VPA, SIM + VPA received valproic acid(300 mg/kg/day), valproic acid(300 mg/kg/day) plus SIM (25 mg/kg/day), respectively, treatment until death at 12 weeks. Micro-CT, histology, biomechanical testing, bone metabolism index and Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis were used to observe the therapeutic effect and explore the possible mechanism. Results shown that VPA decreased new bone formation around the surface of titanium rods and push-out force other than group OVX. Histology, Micro-CT and biochemical analysis results showed combined application of systemic VPA showed harmful effects than OVX group on bone formation in osteopenic rats, with the worse effects on CTX-1, P1NP and microarchitecture as well as biomechanical parameters by down-regulated gene expression of Runx2, OCN, Smad1, BMP-2 and OPG, while up-regulated RANKL. However, after SIM treatment, the above indicators were significantly improved. The present study suggests that systemic use of VPA may bring harm to the stability of titanium implants in osteoporosis, SIM can reverse the negative effect of VPA on the osseointegration of titanium rods in ovariectomized rats.
    MeSH term(s) 3T3 Cells ; Animals ; Anticonvulsants/administration & dosage ; Anticonvulsants/toxicity ; Female ; Gene Expression Regulation ; Mice ; Osseointegration/drug effects ; Osteogenesis/drug effects ; Osteoporosis/genetics ; Osteoporosis/pathology ; Osteoporosis/therapy ; Ovariectomy ; Prostheses and Implants ; Prosthesis Design ; Rats ; Rats, Sprague-Dawley ; Simvastatin/administration & dosage ; Simvastatin/pharmacology ; Titanium/chemistry ; Valproic Acid/administration & dosage ; Valproic Acid/toxicity ; X-Ray Microtomography
    Chemical Substances Anticonvulsants ; Valproic Acid (614OI1Z5WI) ; Simvastatin (AGG2FN16EV) ; Titanium (D1JT611TNE)
    Language English
    Publishing date 2020-10-14
    Publishing country France
    Document type Journal Article
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2020.110745
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Aspirin modified strontium-doped β-tricalcium phosphate can accelerate the healing of femoral metaphyseal defects in ovariectomized rats.

    Tao, Zhou-Shan / Zhou, Wan-Shu / Xu, Hong-Guang / Yang, Min

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2020  Volume 132, Page(s) 110911

    Abstract: The purpose was to observe whether local administration Strontium (Sr) and Aspirin (Asp) can enhance the efficacy of β-Tricalcium phosphate(β-TCP) in the treatment of osteoporotic bone defect. The MC3T3-E1 cells were co-cultured with β-TCP, Sr/β-TCP, Asp- ...

    Abstract The purpose was to observe whether local administration Strontium (Sr) and Aspirin (Asp) can enhance the efficacy of β-Tricalcium phosphate(β-TCP) in the treatment of osteoporotic bone defect. The MC3T3-E1 cells were co-cultured with β-TCP, Sr/β-TCP, Asp-Sr/β-TCP scaffold and induced to osteogenesis, and the cell viability, mineralization ability were observed by MTT, Alizarin Red staining(ARS) and Western blotting(WB). Then this scaffolds were implanted into the femoral epiphysis bone defect model of ovariectomized(OVX) rats for 8 weeks. X-ray, Micro-CT, histology and Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis were used to observe the therapeutic effect and explore the possible mechanism. MTT, ARS results show that the cell mineralization and viability of Asp-Sr/β-TCP group is significantly higher than Control group, β-TCP group and Sr/β-TCP group. Protein expression show that the osteogenic protein expression such as ALP、OP、RUNX-2、OC and COL-1 of Asp-Sr/β-TCP group is significantly higher than Control group, β-TCP group and Sr/β-TCP group. X-ray images, Micro-CT and Histological analysis evaluation show that, group Asp-Sr/β-TCP presented the strongest effect on bone regeneration and bone mineralization, when compared with β-TCP group and Sr/β-TCP group. RT-qPCR analysis show that Asp-Sr/β-TCP, β-TCP group and Sr/β-TCP group showed increased BMP2, Smad1, OPG than the OVX group(p < 0.05), while Asp-Sr/β-TCP exhibited decreased TNF-α、IFN-γ and RANKL than the OVX group(p < 0.05). Our current study demonstrated that Asp-Sr/ β-TCP is a scheme for rapid repair of femoral condylar defects, and these effects may be achieved by inhibiting local inflammation and through BMP-2/Smad1 and OPG/RANKL signaling pathway.
    MeSH term(s) 3T3 Cells ; Animals ; Anti-Inflammatory Agents/pharmacology ; Aspirin/pharmacology ; Bone Density/drug effects ; Bone Morphogenetic Protein 2/metabolism ; Bone Remodeling/drug effects ; Bone Substitutes/pharmacology ; Calcium Phosphates/pharmacology ; Disease Models, Animal ; Female ; Femur/drug effects ; Femur/metabolism ; Femur/pathology ; Humans ; Mice ; Osteoblasts/drug effects ; Osteoblasts/metabolism ; Osteoblasts/pathology ; Osteogenesis/drug effects ; Osteoporosis, Postmenopausal/drug therapy ; Osteoporosis, Postmenopausal/metabolism ; Osteoporosis, Postmenopausal/pathology ; Osteoprotegerin/metabolism ; Ovariectomy ; RANK Ligand/metabolism ; Rats, Sprague-Dawley ; Signal Transduction ; Smad1 Protein/metabolism ; Strontium/pharmacology ; Wound Healing/drug effects
    Chemical Substances Anti-Inflammatory Agents ; Bmp2 protein, rat ; Bone Morphogenetic Protein 2 ; Bone Substitutes ; Calcium Phosphates ; Osteoprotegerin ; RANK Ligand ; Smad1 Protein ; Smad1 protein, rat ; Tnfrsf11b protein, rat ; beta-tricalcium phosphate ; Aspirin (R16CO5Y76E) ; Strontium (YZS2RPE8LE)
    Language English
    Publishing date 2020-10-28
    Publishing country France
    Document type Comparative Study ; Journal Article
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2020.110911
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Resveratrol reverses the negative effect of alcohol on hydroxyapatite-coated implant osseointegration in senile female rats.

    Tao, Zhou-Shan / Zhou, Wan-Shu / Yang, Min / Xu, Hongguang

    Zeitschrift fur Gerontologie und Geriatrie

    2019  Volume 53, Issue 6, Page(s) 538–545

    Abstract: Previous studies have demonstrated the damaging effect of alcohol (ALH) consumption on bone tissue and bone metabolism. Resveratrol (RES) promotes osteoblast proliferation and inhibits osteoclast proliferation and positively affects bone regeneration; ... ...

    Title translation Resveratrol kehrt den negativen Effekt von Alkohol auf die Osseointegration hydroxylapatitbeschichteter Implantate bei alten weiblichen Ratten um.
    Abstract Previous studies have demonstrated the damaging effect of alcohol (ALH) consumption on bone tissue and bone metabolism. Resveratrol (RES) promotes osteoblast proliferation and inhibits osteoclast proliferation and positively affects bone regeneration; however, reports about effects of RES on osseointegration in aged female rats with ALH consumption are limited. This study was designed to investigate the impact of treatment with RES on osseointegration for aged female rats with ALH consumption. This study included 30 female Sprague-Dawley rats (22 months old), weighing approximately 520 g. All animals were randomly divided into 3 groups of 10: a control group (CON) receiving saline, a group receiving ALH and a group receiving ALH + RES until death after 12 weeks. The results of enhanced osseointegration in senile female rats with RES consumption were evaluated by histology, microcomputerized tomography (micro-CT), gene expression analysis and a biomechanical test. The results of this study indicated that ALH + RES showed stronger effects on the improvement of osseointegration in senile female rats with ALH consumption. The ALH + RES produced stronger effects on bone volume per total volume (BV/TV), mean trabecular thickness (Tb.Th), mean trabecular number (Tb.N) and mean trabecular separation (Tb.Sp), connective tissue density (Conn.D) and maximum push-out force for implants, and regulation of osteogenesis and bone resorption-related gene expression. These results seem to indicate that RES intervention reverses the negative effect of alcohol on hydroxyapatite-coated implant osseointegration in senile female rats with ALH consumption.
    MeSH term(s) Animals ; Durapatite ; Female ; Osseointegration ; Rats ; Rats, Sprague-Dawley ; Resveratrol/pharmacology ; Titanium ; X-Ray Microtomography
    Chemical Substances Durapatite (91D9GV0Z28) ; Titanium (D1JT611TNE) ; Resveratrol (Q369O8926L)
    Language English
    Publishing date 2019-08-21
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1227032-5
    ISSN 1435-1269 ; 0044-281X ; 0948-6704
    ISSN (online) 1435-1269
    ISSN 0044-281X ; 0948-6704
    DOI 10.1007/s00391-019-01595-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment.

    Sabel, Bernhard A / Zhou, Wanshu / Huber, Frank / Schmidt, Florentina / Sabel, Kornelia / Gonschorek, Andreas / Bilc, Mirela

    Restorative neurology and neuroscience

    2021  Volume 39, Issue 6, Page(s) 393–408

    Abstract: Background: An effective treatment is needed for long-COVID patients which suffer from symptoms of vision and/or cognition impairment such as impaired attention, memory, language comprehension, or fatigue.: Objective: Because COVID-19infection causes ...

    Abstract Background: An effective treatment is needed for long-COVID patients which suffer from symptoms of vision and/or cognition impairment such as impaired attention, memory, language comprehension, or fatigue.
    Objective: Because COVID-19infection causes reduced blood flow which may cause neuronal inactivation, we explored if neuromodulation with non-invasive brain stimulation using microcurrent (NIBS), known to enhance blood flow and neuronal synchronization, can reduce these symptoms.
    Methods: Two female long-COVID patients were treated for 10-13 days with alternating current stimulation of the eyes and brain. While one patient (age 40) was infected with the SARS CoV-2 virus, the other (age 72) developed symptoms following AstraZeneca vaccination. Before and after therapy, cognition was assessed subjectively by interview and visual fields quantified using perimetry. One patient was also tested with a cognitive test battery and with a retinal dynamic vascular analyser (DVA), a surrogate marker of vascular dysregulation in the brain.
    Results: In both patients NIBS markedly improved cognition and partially reversed visual field loss within 3-4 days. Cognitive tests in one patient confirmed recovery of up to 40-60% in cognitive subfunctions with perimetry results showing stable and visual field recovery even during follow-up. DVA showed that NIBS reduced vascular dysregulation by normalizing vessel dynamics (dilation/constriction), with particularly noticeable changes in the peripheral veins and arteries.
    Conclusions: NIBS was effective in improving visual and cognitive deficits in two confirmed SARS-COV-2 patients. Because recovery of function was associated with restoration of vascular autoregulation, we propose that (i) hypometabolic, "silent" neurons are the likely biological cause of long-COVID associated visual and cognitive deficits, and (ii) reoxygenation of these "silent" neurons provides the basis for neural reactivation and neurological recovery. Controlled trials are now needed to confirm these observations.
    MeSH term(s) Adult ; Aged ; Brain ; COVID-19/complications ; Cognitive Dysfunction/therapy ; Cognitive Dysfunction/virology ; Electric Stimulation Therapy ; Female ; Humans ; Vision Disorders/therapy ; Vision Disorders/virology
    Language English
    Publishing date 2021-11-19
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1017098-4
    ISSN 1878-3627 ; 0922-6028
    ISSN (online) 1878-3627
    ISSN 0922-6028
    DOI 10.3233/RNN-211249
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Co-modification of calcium phosphate cement to achieve rapid bone regeneration in osteoporotic femoral condyle defect with lithium and aspirin.

    Tao, Zhou-Shan / Zhou, Wan-Shu / Zhang, Rou-Tian / Li, Yang / Xu, Hong-Guang / Wei, Shan / Wang, Zheng-Yu / Yang, Min

    American journal of translational research

    2021  Volume 13, Issue 3, Page(s) 952–966

    Abstract: Local application of lithium or aspirin with biological scaffold has been identified as a potent means to improve bone formation. In this study, lithium and aspirin modified calcium phosphate cement (Asp-Li/CPC) was prepared, and the feasibility of this ... ...

    Abstract Local application of lithium or aspirin with biological scaffold has been identified as a potent means to improve bone formation. In this study, lithium and aspirin modified calcium phosphate cement (Asp-Li/CPC) was prepared, and the feasibility of this biological scaffold in the treatment of osteoporotic bone defect was observed in vivo and in vitro. In vitro experiments confirmed that Asp-Li/CPC had better ability to promote MC3T3-E1 cells differentiation into osteoblasts, osteoblast mineralization and viability, and promote cell expression of ALP, OP, RUNX-2, OC and COL-1 protein than simple CPC or lithium modified CPC by MTT, Alizarin red staining and Western blot evaluation. In vivo experiments confirmed that Asp-Li/CPC presented the strongest effect on bone regeneration and bone mineralization through the comparison with CPC group and Li/CPC group with X-ray images, Micro-CT and Histological evaluation. RT-qPCR analysis showed that Asp-Li/CPC, Li/CPC group and CPC group demonstrated increased BMP2, Smad1, OPG than the OVX group (P<0.05), while Asp-Li/CPC exhibited decreased TNF-α, IFN-γ and RANKL than the OVX group (P<0.05). Experiments in vivo and in vitro show that Asp-Li/CPC is a scheme for rapid repair of femoral condylar defects, and these effects may be achieved by inhibiting local inflammation and through BMP-2/Smad1 and OPG/RANKL signaling pathway.
    Language English
    Publishing date 2021-03-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2471058-1
    ISSN 1943-8141
    ISSN 1943-8141
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top